Eco R1 Capital, LLC I Teos Therapeutics, Inc. Call Options Transaction History
Eco R1 Capital, LLC
- $1.16 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITOS
# of Institutions
144Shares Held
37.7MCall Options Held
733KPut Options Held
611K-
Tang Capital Management LLC San Diego, CA3.83MShares$38.6 Million2.28% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$37.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY1.98MShares$20 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$16.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX833KShares$8.41 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $359M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...